Tag: vaccine manufacturing
Advanced vaccine manufacturing in Australia to supply Canada with 15 million pandemic doses
Advanced vaccine manufacturing in Australia is set to support Canada’s pandemic preparedness plans after Australian manufacturer CSL Seqirus secured a contract to supply influenza vaccines in the event of a future global outbreak.
$1 billion cell-based vaccine manufacturing facility opens in Melbourne
CSL Seqirus has officially opened its $1 billion plant in Tullamarine, described as the Southern Hemisphere’s first cell-based vaccine manufacturing facility.
Vaxxas raises $90M to advance needle-free vaccine manufacturing
Vaxxas Pty Ltd has secured around $90 million in new funding to accelerate the commercialisation and manufacturing of its needle-free vaccine delivery technology.
Moderna announces new head of mRNA vaccine manufacturing site in Melbourne
Global medical technology company Moderna has appointed Emma Harrington as the inaugural manufacturing site head for the company’s new mRNA vaccine manufacturing site in Australia.
University of Adelaide projects win grants to foster research partnerships
Researchers from the University of Adelaide have received federal grants that will support two projects that will help develop a vaccine to protect poultry against salmonella and identify important plant compounds.
National team of experts developing technology to boost Australia’s vaccine manufacturing capability
A team of scientific experts are developing a biopolymer particle-based platform technology that will bring Australia a step closer towards establishing a sovereign capability to rapidly manufacture vaccines against emerging infectious diseases.
Moderna’s vaccine manufacturing hub in Victoria nears completion ahead of schedule
Victoria is one step closer to locally manufacturing mRNA vaccines and medicines, with the construction of Moderna’s mRNA vaccine manufacturing facility reaching the halfway mark, progressing faster than originally planned.
Moderna establishes mRNA Regional Research Centre, HQ in Melbourne
Biotechnology giant Moderna is opening a Regional Research Centre and Headquarters in Melbourne, boosting advancements in the local mRNA industry in Victoria.
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Victoria backs Monash’s advanced mRNA vaccine manufacturing training centre
The Victorian government has announced a $10 million investment in the Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training.
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
